New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Search Results for
New Blood: Former Novartis Exec Transitions to Rubius Therapeutics...
August 17, 2017
... in the clinic by late 2018, with others to follow in 2019. The technology has already shown promising early results in mouse models of multiple sclerosis and type 1 diabetes. ...
Walnuts' Appetite-Control Mechanism Visualized in Brain
August 17, 2017
Findings from the study were published recently in Diabetes, Obesity, and Metabolism in an ... in the division of endocrinology, diabetes, and metabolism at BIDMC. "We know ...
Precision Medicine for Preventing Suicide
August 15, 2017
... They included medications already in use to treat psychiatric illnesses and drugs approved for other uses, such as the diabetes medication metformin." Dr. Niculescu points out that ...
Does a Common Food Preservative Trigger Obesity?
August 11, 2017
... with long-term metabolic dysfunction in obesity and type 2 diabetes, the authors state. ... diseases like obesity and type 2 diabetes, the platform described here has ...
Gene Study Based on RNA Interference May Lead to New Liver Cancer...
August 11, 2017
Nearly half of these studies were published in the last two years. Research on SLC13A5 has focused on its role in obesity and diabetes; knocking out the SLC13A5 gene in mice ...
Up to Code
August 8, 2017
... diabetes have been done in Caucasians," said Dr. Rotter. LABioMed has specifically worked to make sure their biobank is diverse. "We have already found novel variants in diabetes ...
CRISPR Gene Therapy via Skin Grafts Treats Obesity and Diabetes...
August 3, 2017
CRISPR Gene Therapy via Skin Grafts Treats Obesity and Diabetes in Mice Ashley Jean Yeager Genetically engineered skin cells grafted onto mice can treat the animals' diabetes and ...
Merck, Samsung Bioepis Launch Remicade Biosimilar in U.S.
July 24, 2017
... marketed diabetes treatment Lantus® (insulin glargine). Merck and Samsung Bioepis began collaborating on biosimilars in 2013, then expanded their alliance to diabetes treatments ...
Merck Wins Tentative FDA Approval for Lusduna
July 20, 2017
infringes on patents for its marketed diabetes treatment Lantus® (insulin glargine). ... Merck clinical research, diabetes, endocrinology, and women's health, said in a statement. ...
Mouth Microbiome Altered by Diabetes Fosters Periodontitis |...
July 13, 2017
More » July 13, 2017 Mouth Microbiome Altered by Diabetes Fosters Periodontitis The past ... oral microbiome is affected by diabetes, causing a shift to increase its pathogenicity. ...